Shionogi Inc. Press Release: SHIONOGI RECEIVES FDA APPROVAL FOR OSPHENA (OSPEMIFENE) FOR THE TREATMENT OF DYSPAREUNIA, A SYMPTOM OF VULVAR AND VAGINAL ATROPHY (VVA), DUE TO MENOPAUSE
This website uses cookies for analytics and functionality purposes. To change your cookie settings or find out more, click here.
If you continue browsing our website, you accept these cookies.
